Talaris Therapeutics, Inc.
New Filing
CIK: 0001827506·Biotechnology·DELAWARE·Filed: Oct 7, 2020
Total Offering
$114,999,989
Amount Sold
$114,999,989
Investors
24
First Sale
Sep 22, 2020
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Suzanne Ildstad | Related Person |
| Nick Galakatos | Related Person |
| Sandip Agarwala | Related Person |
| Mark McDade | Related Person |
| Francois Nader | Related Person |
| Geoff Mackay | Related Person |
| Scott Requadt | Related Person |
Company
SEC Filing
0001827506-20-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free